Jazz Pharmaceuticals (JAZZ) Restructuring Costs (2011 - 2018)
Jazz Pharmaceuticals (JAZZ) posted quarterly Restructuring Costs of $44.0 million for Q2 2018, up 307.41% quarter-over-quarter from $10.8 million in Q3 2016.
Powered by 
Analysis
Jazz Pharmaceuticals (JAZZ) Restructuring Costs (2011 - 2018) Analysis & Trends
Jazz Pharmaceuticals' Restructuring Costs history runs 6 years deep, the most recent figure standing at $44.0 million for Q2 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Jazz Pharmaceuticals | 15.60 Bn | 13.98 Bn | 1.09 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2018 | 44.00 Mn |
| Sep 30, 2016 | 10.80 Mn |
| Jun 30, 2016 | 2.20 Mn |
| Sep 30, 2014 | 700,000.00 |
| Jun 30, 2014 | 4.40 Mn |
| Mar 31, 2014 | 17.10 Mn |
| Jun 30, 2013 | 400,000.00 |
| Jun 30, 2012 | 8.90 Mn |
| Mar 31, 2012 | 3.50 Mn |
| Sep 30, 2011 | 6.00 Mn |